Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptimmune Therapeutics PLC

0.2139
-0.0011-0.51%
Volume:176.31K
Turnover:38.75K
Market Cap:55.02M
PE:-0.71
High:0.2408
Open:0.2408
Low:0.2121
Close:0.2150
Loading ...
Nov 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 01, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Sep 30, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 06, 2019

Correspondence

[Cover]Correspondence
Aug 30, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 27, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Aug 07, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 05, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Aug 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 01, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 01, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Aug 01, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 25, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jul 22, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jul 18, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities